Eversept Partners as of Dec. 31, 2022
Portfolio Holdings for Eversept Partners
Eversept Partners holds 64 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
GSK Sponsored Adr (GSK) | 11.4 | $124M | 3.5M | 35.48 | |
Horizon Therapeutics Pub L SHS | 11.2 | $121M | 1.1M | 113.80 | |
Natera (NTRA) | 10.0 | $108M | 2.7M | 40.17 | |
Sanofi Sponsored Adr (SNY) | 7.2 | $78M | 1.6M | 48.43 | |
United Therapeutics Corporation (UTHR) | 6.0 | $65M | 233k | 278.09 | |
Danaher Corporation (DHR) | 4.0 | $43M | 163k | 265.67 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 4.0 | $43M | 4.7M | 9.12 | |
Syndax Pharmaceuticals (SNDX) | 3.8 | $41M | 1.6M | 25.45 | |
Biogen Idec (BIIB) | 3.5 | $38M | 137k | 276.92 | |
Catalent (CTLT) | 2.9 | $31M | 692k | 45.01 | |
Illumina (ILMN) | 2.6 | $28M | 140k | 202.20 | |
Celldex Therapeutics Com New (CLDX) | 2.3 | $25M | 559k | 44.57 | |
Envista Hldgs Corp (NVST) | 2.0 | $22M | 642k | 33.67 | |
GSK Call | 1.8 | $20M | 21k | 944.13 | |
Spdr Ser Tr S&p Biotech (XBI) | 1.7 | $18M | 216k | 83.00 | |
Centene Corporation (CNC) | 1.6 | $18M | 215k | 82.01 | |
Haleon Spon Ads (HLN) | 1.4 | $15M | 1.9M | 8.00 | |
Anthem Inc opt | 1.3 | $14M | 28k | 512.97 | |
Icon SHS (ICLR) | 1.2 | $13M | 67k | 194.25 | |
Avantor (AVTR) | 1.2 | $13M | 600k | 21.09 | |
Tenet Healthcare Corp Com New (THC) | 1.1 | $12M | 255k | 48.79 | |
Seres Therapeutics (MCRB) | 1.1 | $12M | 2.2M | 5.60 | |
Xenon Pharmaceuticals (XENE) | 1.0 | $11M | 276k | 39.43 | |
Humana (HUM) | 1.0 | $11M | 21k | 512.96 | |
BioCryst Pharmaceuticals (BCRX) | 0.9 | $10M | 881k | 11.48 | |
Repligen Corporation (RGEN) | 0.9 | $9.7M | 57k | 169.31 | |
Ionis Pharmaceuticals (IONS) | 0.8 | $9.1M | 241k | 37.77 | |
Model N (MODN) | 0.8 | $8.8M | 218k | 40.56 | |
Community Health Systems (CYH) | 0.8 | $8.6M | 2.0M | 4.32 | |
Vaxcyte (PCVX) | 0.8 | $8.6M | 179k | 47.95 | |
Liquidia Corporation Com New (LQDA) | 0.8 | $8.2M | 1.3M | 6.37 | |
Apellis Pharmaceuticals (APLS) | 0.7 | $8.0M | 155k | 51.71 | |
Vera Therapeutics Cl A (VERA) | 0.7 | $8.0M | 411k | 19.35 | |
Iveric Bio | 0.7 | $7.5M | 351k | 21.41 | |
Taro Pharmaceutical Inds SHS (TARO) | 0.6 | $6.5M | 226k | 29.04 | |
Puma Biotechnology (PBYI) | 0.6 | $6.4M | 1.5M | 4.23 | |
Evolus (EOLS) | 0.5 | $5.4M | 714k | 7.51 | |
Incyte Corporation (INCY) | 0.5 | $5.1M | 64k | 80.32 | |
Merck & Co Call | 0.4 | $4.8M | 487.00 | 9856.02 | |
Spdr Ser Tr Call | 0.4 | $4.3M | 900.00 | 4823.22 | |
Guardant Health (GH) | 0.4 | $4.0M | 146k | 27.20 | |
Amarin Corp Spons Adr New | 0.4 | $4.0M | 3.3M | 1.21 | |
Merus N V (MRUS) | 0.3 | $2.9M | 185k | 15.47 | |
Aerovate Therapeutics (AVTE) | 0.2 | $2.7M | 91k | 29.30 | |
Pliant Therapeutics (PLRX) | 0.2 | $2.7M | 137k | 19.33 | |
Cabaletta Bio (CABA) | 0.2 | $2.6M | 283k | 9.25 | |
Biohaven (BHVN) | 0.2 | $2.6M | 186k | 13.88 | |
Iqvia Holdings (IQV) | 0.2 | $2.2M | 11k | 204.89 | |
Agilent Technologies Inc C ommon (A) | 0.2 | $1.8M | 12k | 149.88 | |
Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.2 | $1.7M | 831k | 1.99 | |
Xoma Corp Del Com New (XOMA) | 0.1 | $1.6M | 87k | 18.40 | |
PerkinElmer (RVTY) | 0.1 | $1.6M | 11k | 140.22 | |
Bio-techne Corporation (TECH) | 0.1 | $1.4M | 17k | 82.88 | |
Argenx Se Sponsored Adr (ARGX) | 0.1 | $1.3M | 3.5k | 378.83 | |
Aadi Bioscience (AADI) | 0.1 | $1.3M | 102k | 12.83 | |
Teva Pharmaceutical Inds Call | 0.1 | $1.3M | 2.7k | 472.67 | |
Heska Corp Com Restrc New | 0.1 | $1.2M | 20k | 62.16 | |
Gohealth Cl A New (GOCO) | 0.0 | $528k | 51k | 10.45 | |
Fate Therapeutics (FATE) | 0.0 | $440k | 44k | 10.09 | |
Affimed Therapeutics B V | 0.0 | $410k | 330k | 1.24 | |
Community Health Sys Call | 0.0 | $406k | 3.1k | 129.70 | |
Gossamer Bio (GOSS) | 0.0 | $335k | 154k | 2.17 | |
Glycomimetics (GLYC) | 0.0 | $305k | 101k | 3.03 | |
Ac Immune Sa SHS (ACIU) | 0.0 | $254k | 125k | 2.04 |